基因编码钾离子指示剂测定的唾液钾作为血液透析患者血浆钾水平的替代指标:一项概念验证研究
该概念验证研究纳入20名健康志愿者及29名血液透析患者连续三次透析前后的血浆和唾液样本,比较基因编码钾离子指示剂(GEPII)与离子选择性电极(ISE)测定唾液钾的一致性,并评估唾液钾能否反映血浆钾变化。GEPII测定唾液钾表现优异,透析后血浆钾和唾液钾均显著下降且动力学相似,但两者相关性弱或无。
要点
- GEPII测定唾液钾与ISE法一致性良好(偏倚0.71,95%一致性界限-2.79至4.40)。
- 透析前患者唾液钾中位数37.7 mmol/L,显著高于健康对照的23.8 mmol/L(P<.05)。
- 透析后血浆钾和唾液钾均显著下降,但两者相关性弱或无。
核心结论
- GEPII在测定唾液钾方面表现优异,血浆钾与唾液钾呈现相似动力学,但唾液能否作为监测血浆钾的合适样本类型需未来研究进一步验证。
研究设计与样本
- 概念验证研究,纳入20名健康志愿者及29名血液透析患者,收集连续三次透析前后的血浆和唾液样本,比较GEPII与离子选择性电极测定唾液钾。
主要发现
- Bland-Altman分析显示GEPII与ISE之间一致性良好(偏倚0.71,95%一致性界限-2.79至4.40)。
- 透析前血液透析患者唾液钾中位数37.7(30.85; 48.46)mmol/L,显著高于健康对照的23.8(21.63; 25.23)mmol/L(P<.05)。
- 血液透析患者血浆钾在透析后显著下降,唾液钾也平行显著下降,两者均上升至下一次透析。
- 尽管动力学相似,血浆钾与唾液钾之间相关性弱或无。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hyperkalemia is a common complication in cardiorenal patients treated with agents interfering with renal potassium (K+) excretion. It frequently leads to discontinuation of potentially life-saving medication, which has increased the importance of K+ monitoring. Non-invasive means to detect hyperkalemia are currently unavailable, but would be of potential use for therapy guidance. The aim of the present study was to assess the analytical performance of genetically encoded potassium-ion indicators (GEPIIs) in measuring salivary [K+] ([K+]Saliva) and to determine whether changes of [K+]Saliva depict those of [K+]Plasma. METHODS: We conducted this proof-of-concept study: saliva samples from 20 healthy volunteers as well as plasma and saliva from 29 patients on hemodialysis (HD) before and after three consecutive HD treatments were collected. We compared [K+]Saliva as assessed by the gold standard ion-selective electrode (ISE) with GEPII measurements. RESULTS: The Bland-Altmann analysis showed a strong agreement (bias 0.71; 95% limits of agreement from -2.79 to 4.40) between GEPII and ISE. Before treatment, patients on HD showed significantly higher [K+]Saliva compared with healthy controls [median 37.7 (30.85; 48.46) vs 23.8 (21.63; 25.23) mmol/L; P < .05]. [K+]Plasma in HD patients decreased significantly after dialysis. This was paralleled by a significant decrease in [K+]Saliva, and both parameters increased until the subsequent HD session. Despite similar kinetics, we found weak or no correlation between [K+]Plasma and [K+]Saliva. CONCLUSION: GEPIIs have shown an excellent performance in determining [K+]Saliva. [K+]Plasma and [K+]Saliva exhibited similar kinetics. To determine whether saliva could be a suitable sample type to monitor [K+]Plasma, further testing in future studies are required.
引用
- Deak AT, Belić K, Meissl AM, et al. Salivary potassium measured by genetically encoded potassium ion indicators as a surrogate for plasma potassium levels in hemodialysis patients-a proof-of-concept study. Nephrol Dial Transplant. 2023. PMID: 35700151. doi:10.1093/ndt/gfac195
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。